Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells

Cancer Research

Volumn 57, Issue 18, 1997, Pages 3924-3928

  Yoshiji, Hitoshi ^a,b   Harris, Steven R ^a   Thorgeirsson, Unnur P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CELL SURFACE RECEPTOR; TRANSFORMING GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CARCINOMA CELL; CELL PROLIFERATION; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; RECEPTOR DENSITY; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENETIC VECTORS; HUMANS; LYMPHOKINES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PLATELET-DERIVED GROWTH FACTOR; RNA, MESSENGER; RNA, NEOPLASM; TRANSFORMING GROWTH FACTORS; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030823968     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
2. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., and Gasparini, G. Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma. J. Natl. Cancer Inst., 84: 1875-1887, 1992.
3. Dvorak, H. F., Detmar, M., Claffey, K. P., Nagy, J. A., Van De Water, L., and Senger, D. R. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int. Arch. Allergy Appl. Immunol., 107: 233-235, 1995.
4. Shibuya, M. Role of VEGF-Flt receptor system in normal and tumor angiogenesis. Adv. Cancer Res., 67: 281-316, 1995.
5. Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res., 55: 3964-3968, 1995.
6. Toi, M., Inada, K., Suzuki, H., and Tominaga, T. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res. Treat., 36: 193-204, 1995.
7. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (Lond.), 362: 841-844, 1993.
8. Saleh, M., Stacker, S. A., and Wilks, A. F. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res., 56: 393-401, 1996.
9. 121. Cancer Res., 55: 5296-5301, 1995.
10. Cheng, S., Su Huang, H., Nagane, M., Ji, X., Wang, D., Shih, C. C., Arap, W., Huang, C., and Cavenee, W. K. Suppression of glioblastoma angiogenicity and tumongenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA. 93: 8502-8507, 1996.
11. Claffey, K. P., Brown, L. F., del Aguila, L. F., Tognazzi, K., Yeo, K., Manseau, E. J., and Dvorak, H. F. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res., 56: 172-181, 1996.
12. Zhang, H., Craft, P., Scott, P. A. E., Ziche, M., Weich, H. A., Harris, A. L., and Bicknell, R. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J. Natl. Cancer Inst., 87: 213-219, 1995.
13. Potgens, A. J. G., van Altena, M. C., Lubsen, N. H., Ruiter, D. J., and de Waal, R. M. W. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor. Am. J. Pathol., 148: 1203-1217, 1996.
14. Gossen, M., and Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA, 89: 5547-5551, 1992.
15. Paulus, W., Baur, I., Boyce, F. M., Breakefield, X. O., and Reeves, S. A. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J. Virol., 70: 62-67, 1996.
16. Yu, J. S., Sena-Esteves, M., Paulus, W., Breakefield, X. O., and Reeves, S. A. Retroviral delivery and tetracycline-dependent expression of IL-1β-converting enzyme (ICE) in a rat glioma model provides controlled induction of apoptotic death in tumor cells. Cancer Res., 56: 5423-5427, 1996.
17. Egawa, S., Tsutsumi, M., Konishi, Y., Kobari, M., Matsuno, S., Nagasaki, K., Futami, H., and Yamaguchi, K. The role of angiogenesis in the tumor growth of Syrian hamster pancreatic cancer cell line-HPD-NR. Gastroenterology, 108: 1526-1533, 1995.
18. Ferrara, N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res. Treat., 36: 127-137, 1995.
19. Yoshiji, H., Gomez, D. E., Shibuya, M., and Thorgeirsson, U. P. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res., 56: 2013-2016, 1996.
20. Masood, R., Cai, J., Zheng, T., Smith, D. L., Naidu, Y., and Gill, P. S. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc. Natl. Acad. Sci. USA, 94: 979-984, 1997.
21. Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., and Connolly, D. T. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (Washington DC), 246: 1309-1312, 1989.